Colorcon Adds New Film Coating System
PTSM: Pharmaceutical Technology Sourcing and Management
The new system will be used for multiparticulate dosages.
Colorcon has added a new film coating system, Opadry EC, Ethylcellulose Organic Coating System for multiparticulate dosages. In an April 13, 2016 press announcement, Colorcon said it continues to see market growth in multiparticulate dosage forms, particularly for geriatric and pediatric populations. Opadry EC provides a solvent coating option that enables a range of release profiles for these specialist dosage forms.
“The base polymer for this system, ethylcellulose, is widely used in the pharmaceutical industry as an insoluble barrier membrane coating; this provides extended release profiles and taste-mask options for granules and orally-disintegrating tablet (ODT) dosages, said Pankaj Rege, general manager, Manufactured Excipients at Colorcon. “This innovative addition to our portfolio of coatings expands the tools available for modifying drug release profiles. As a ready-to-use system, Opadry EC means cost effective and consistent coating performance, and helps to reduce potential errors that may occur during raw material handling and manufacturing.”
Source: Colorcon
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
